On Monday, Wyndham Worldwide Corporation (NYSE:WYN)’s shares declined -0.87% to $81.80.
Wyndham Hotel Group is set to expand its presence in South Korea by more than 200 percent over the next three years thanks to the signings of 12 new property franchise agreements so far in 2015, counting agreements for three Howard Johnson® hotels, marking the brand’s entry into South Korea.
This year’s signings build upon another 14 franchise agreements in South Korea executed by Wyndham Hotel Group in 2014, bringing the company’s pipeline in the country to more than 7,550 rooms within 26 new-construction hotels under the Ramada®, Days Inn® and Howard Johnson brand flags. Presently, Wyndham Hotel Group has 13 properties and more than 2,800 rooms open and operating in the country.
Wyndham Worldwide Corporation provides hospitality services and products to individual consumers and business customers worldwide. It operates three in segments: Lodging, Vacation Exchange, and Rentals, and Vacation Ownership. The Lodging segment franchises hotels in the upscale, upper midscale, midscale, economy, and extended stay segments, in addition to provides property administration services for full-service and select limited-service hotels. As of February 4, 2015, the company had about 7,440 franchised hotels and 638,300 hotel rooms.
Cheetah Mobile Inc (ADR) (NYSE:CMCM)’s shares dropped -3.86% to $25.67.
Cheetah Mobile Inc. (CMCM) a leading mobile Internet company that provides mission critical applications to assist make the Internet and mobile experience speedier, simpler, and safer for users worldwide, recently declared that it plans to release its second quarter 2015 financial results on Tuesday, August 18, 2015 before market opens.
Cheetah Mobile Inc. operates a platform that offer mobile and PC applications for users and global content distribution channels for business partners in China. The companys suite of applications optimizes mobile and PC Internet system performance and provides real time protection against known and unknown security threats. Its mobile and PC applications for users comprise Clean Master, a junk file cleaning, memory boosting, and privacy protection tool for mobile devices; CM Security, an anti-virus and security application for mobile devices; Battery Doctor, a power optimization tool for mobile devices; Cheetah Browser, a safe Web browser for PCs and mobile devices; and CM Launcher, which is a secure launcher that offers acceleration, secure protection, and stylish wallpapers, in addition to automatically organizes mobile phones based on personal behavior; Photo Grid, a photo collage application that allows users to create professional looking collages of photos through an intuitive interface for mobile devices; and Duba Anti-virus, an Internet security application for PC and mobile devices.
At the end of Monday s trade, F.N.B. Corp (NYSE:FNB)‘s shares surged 0.07% to $13.79.
F.N.B. Corporation (FNB) declared that the Office of the Comptroller of the Currency has approved the purchase and assumption application by F.N.B.’s largest associate, First National Bank of Pennsylvania, to acquire five branch offices from Bank of America, N.A. which comprise two branches in Berks County, two branches in Lancaster County and one branch in Chester County. There are no additional regulatory approvals needed to complete the transaction.
The transaction is planned to close on September 18, 2015.
F.N.B. Corporation, a financial holding company, provides various financial services to consumers, corporations, governments, and small- to medium-sized businesses primarily in Pennsylvania, eastern Ohio, and northern West Virginia. It operates through four segments: Community Banking, Wealth Administration, Insurance, and Consumer Finance. The Community Banking segment offers various services, counting commercial and individual demand, savings, and time deposit accounts; and commercial, mortgage, and individual installment loans.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), ended its Monday’s trading session with 3.76% gain, and closed at $12.70.
Vanda Pharmaceuticals Inc. (VNDA) declared that four new Fanapt® patents are now listed in the U.S. Food and Drug Administration publication Approved Drug Products With Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Patent number 9,072,742 expires in January 2031. Patent number 9,074,254 expires in December 2031. Patent number 9,074,255 expires in December 2030. Patent number 9,074,256 expires in February 2031.
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. The companys products comprise HETLIOZ, a product for the treatment of non-24-hour sleep-wake disorder; and Fanapt, a product for the treatment of schizophrenia. Its products also comprise Tradipitant, a small molecule neurokinin-1 receptor antagonist that is under the clinical development for the treatment of chronic pruritus in atopic dermatitis; Trichostatin A, a small molecule histone deacetylase inhibitor; and AQW051, a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
